Treating Metastatic Cancer With Anti-VEGFR2 Gene Engineered CD8+ Lymphocytes

Clinical trial recruiting at NIH:

http://clinicaltrials.gov/ct2/show/NCT01218867?term=11-C-0013&rank=1